MANAGEMENT AND ADVISORS

 MANAGEMENT

 

Dr Vasilis Paspaliaris, BSc(Hons), PhD, MD
Chairman and Chief Executive Officer

Mr Peter Milonas, B(SSc), CEP(APMA)
Vice President and Chief Operating Officer

Dr George Kolios, MD, PhD
Chief Scientific and Research Officer

Mr David Strawn, JD
Director of Legal and Compliance

 

MEDICAL AND SCIENTIFIC ADVISORY BOARD

 

Dr Nick Lolatgis, MBBS, FRANZCOG, FRCOG
Obstetrician, Gynecologist, Fertility Specialist

Dr Joseph Purita, MD
Orthopedic Surgeon

Dr Ashley Granot, MBBS, FFMACCS, FACO, FACNEM, ABAARM, MAS5M
Cosmetic Surgeon

Dr Harry Reich, MD, FACOG, FACS
Gynecologist

Professor Demosthenes Bouros, MD, PhD, FCCP
Pulmonologist

Professor Fred Fändrich, MD, PhD
Transplant Surgeon, Immunologist

Mr Peter Milonas, B(SSc), CEP(APMA)

Mr Peter Milonas, B(SSc), CEP(APMA)

Vice President an Chief Operations Officer

Mr Milonas was educated in Melbourne, Australia, initially at La Trobe University, where he completed a Bachelor Degree (Social Sciences) after undertaking studies across a diverse range of disciplines, including Science, Law and Arts, and later at Monash University, where he completed Pharmaceutical Industry specific Post Graduate (APMA CEP) qualifications. His career followed his passion, Health Care, and for the last 20 years he has worked in the Pharmaceutical Industry, developing extensive knowledge and experience in Sales, Marketing and Management across a number of therapeutic areas and medical sectors such as: Biotechnology, Cosmetic Medicine, Ophthalmology, Women’s Health, Surgical & Capital Equipment, Gastroenterology, CNS, Hospital, Aged Care and Pharmacy.

From his early beginnings as a Sales Representative, on the front line, to Business Development, and National Sales & Marketing Management, all the way through to Chief Operating Officer and Director, Mr Milonas has a complete understanding, and perspective, of the intricate world of the Health Care and Pharmaceutical business. Mr. Milonas’ expertise in this area has been acquired over 2 decades of working for some major Health Care/Pharmaceutical organizations in the industry including: Wyeth Ayerst and Lederle Laboratories, international pharmaceutical company, specializing in areas such as, Women’s health, Gastroenterology, Vaccine and CNS markets; Alcon Laboratories & Surgical, an international company specializing in the discovery, development, manufacture and marketing of surgical devices, vision care products and ophthalmic pharmaceuticals; and Australasian Medical & Scientific established with the aim of providing the Australian scientific and medical markets with a range of leading edge products from around the world.

In the last two years, Peter has been instrumental in the development of the business around the incorporated technologies into Adilyfe as he was working as the Business Development Manager of Adistem, General Manager of Paspa Pharmaceuticals, Director and Vice president of Black Arrow Biotech and Chief Operating Officer of Nereen Healthcare.